540 related articles for article (PubMed ID: 18621770)
1. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
Heusch G; Skyschally A; Gres P; van Caster P; Schilawa D; Schulz R
Eur Heart J; 2008 Sep; 29(18):2265-75. PubMed ID: 18621770
[TBL] [Abstract][Full Text] [Related]
2. Effect of heart rate reduction by 4-(N-ethyl-N-phenyl-amino)-1,2-dimethyl-6-(methylamino)pyrimidinium chloride on infarct size in dog.
Schlack W; Ebel D; Grunert S; Halilović S; Meyer O; Thämer V
Arzneimittelforschung; 1998 Jan; 48(1):26-33. PubMed ID: 9522027
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction.
Heusch G
Br J Pharmacol; 2008 Dec; 155(7):970-1. PubMed ID: 18846042
[TBL] [Abstract][Full Text] [Related]
4. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
[TBL] [Abstract][Full Text] [Related]
5. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.
Liu X; Huang Y; Pokreisz P; Vermeersch P; Marsboom G; Swinnen M; Verbeken E; Santos J; Pellens M; Gillijns H; Van de Werf F; Bloch KD; Janssens S
J Am Coll Cardiol; 2007 Aug; 50(8):808-17. PubMed ID: 17707188
[TBL] [Abstract][Full Text] [Related]
7. Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
Schulz R; Rose J; Skyschally A; Heusch G
J Cardiovasc Pharmacol; 1995 Feb; 25(2):216-28. PubMed ID: 7752647
[TBL] [Abstract][Full Text] [Related]
8. Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.
Monnet X; Ghaleh B; Colin P; de Curzon OP; Giudicelli JF; Berdeaux A
J Pharmacol Exp Ther; 2001 Dec; 299(3):1133-9. PubMed ID: 11714904
[TBL] [Abstract][Full Text] [Related]
9. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion.
Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J
J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653
[TBL] [Abstract][Full Text] [Related]
10. No attenuation of ischaemic preconditioning by the calcium antagonist nisoldipine.
Wallbridge DR; Schulz R; Braun C; Post H; Heusch G
J Mol Cell Cardiol; 1996 Aug; 28(8):1801-10. PubMed ID: 8877789
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction.
Skyschally A; Gres P; Hoffmann S; Haude M; Erbel R; Schulz R; Heusch G
Circ Res; 2007 Jan; 100(1):140-6. PubMed ID: 17170366
[TBL] [Abstract][Full Text] [Related]
12. Chronic heart rate reduction facilitates cardiomyocyte survival after myocardial infarction.
Zhang RL; Christensen LP; Tomanek RJ
Anat Rec (Hoboken); 2010 May; 293(5):839-48. PubMed ID: 20225200
[TBL] [Abstract][Full Text] [Related]
13. Conversion of post-systolic wall thickening into ejectional thickening by selective heart rate reduction during myocardial stunning.
Lucats L; Ghaleh B; Monnet X; Colin P; Bizé A; Berdeaux A
Eur Heart J; 2007 Apr; 28(7):872-9. PubMed ID: 17376788
[TBL] [Abstract][Full Text] [Related]
14. Coronary microembolization does not induce acute preconditioning against infarction in pigs-the role of adenosine.
Skyschally A; Schulz R; Gres P; Konietzka I; Martin C; Haude M; Erbel R; Heusch G
Cardiovasc Res; 2004 Aug; 63(2):313-22. PubMed ID: 15249189
[TBL] [Abstract][Full Text] [Related]
15. Pre-occlusion ischaemia, not sevoflurane, successfully preconditions the myocardium against further damage in porcine in vivo hearts.
Larsen JR; Aagaard SR; Hasenkam JM; Sloth E
Acta Anaesthesiol Scand; 2007 Apr; 51(4):402-9. PubMed ID: 17378777
[TBL] [Abstract][Full Text] [Related]
16. Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
Monnet X; Colin P; Ghaleh B; Hittinger L; Giudicelli JF; Berdeaux A
Eur Heart J; 2004 Apr; 25(7):579-86. PubMed ID: 15120055
[TBL] [Abstract][Full Text] [Related]
17. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R
Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966
[TBL] [Abstract][Full Text] [Related]
18. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection by ivabradine through heart rate reduction and beyond.
Heusch G; Skyschally A; Schulz R
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):281-4. PubMed ID: 21821529
[TBL] [Abstract][Full Text] [Related]
20. Contraction band necrosis: its modification by the free radical scavenger N-2-mercaptopropionyl glycine.
Widman SC; Liang CS; Schenk EA; Hood WB
J Cardiovasc Pharmacol; 1994 Nov; 24(5):694-701. PubMed ID: 7532745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
